Skip to content
Trial Eligibility
Menu

Small Extracellular Vesicles and Insulin Action

NCT05933707

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goals of this research study are to: 1) understand why some people with obesity are protected from developing conditions such as type 2 diabetes and cardiovascular disease while others are more likely to develop obesity-related conditions; 2) assess the effect of small extracellular vesicles (sEVs also called exosomes), obtained from human participants, on metabolic function in cultured cells and in mice.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Obesity
  • Insulin Resistance
  • Metabolically Healthy Obesity
  • Obesity, Metabolically Benign

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
25 to 55 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Washington University School of Medicine
Last updated on ClinicalTrials.gov
July 17, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Missouri · 1

  • Washington University School of Medicine · St Louis, MO

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.